Weil, Gotshal & Manges LLP advises biotech, pharma, and medical device companies on a range of corporate, IP, regulatory, and litigation matters. The firm assists clients with mergers and acquisitions, strategic alliances, licensing agreements, and collaborations aimed at expanding life sciences businesses. It also represents companies in disputes involving patents, trade secrets, trademarks, and commercial matters, alongside litigation relating to shareholder issues, product liability, antitrust, and government investigations. Recently hired from Latham & Watkins, Doug Lumish and Jeff Homrig co-head the firm’s IP, technology and science litigation practice. Based in San Francisco and Silicon Valley, Lumish handles patent, trade secret, contract, licensing, and fraud disputes involving technology and life sciences companies, while Homrig, working from Dallas and Houston, represents life sciences companies in complex patent and trade secret litigation, reflecting the firm’s focus on high-stakes IP disputes in the sector. Bolstering the team's expertise is the 'wonderful' Gabe Gross, who specialises in IP and commercial litigation matters and works between the San Francisco and Silicon Valley offices.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘We worked primarily with Gabe Gross and he's been wonderful. He's likely one of the best negotiators I've ever encountered, as well as a great human being in general. It was always a pleasure working with him.’
Key clients
- Regeneron Pharmaceuticals
- CareDx
- Edwards Lifesciences Corporation
- Veracity-Health, Inc. and its Co-Founder
- North American Science Associates
- Sanofi, S.A.
- GoodRx, Inc.
- Chemed Corporation
- Lunan Pharmaceuticals
- Dental Monitoring
- Torrent Pharmaceuticals
- Suven Pharmaceuticals
Work highlights
Won a significant antitrust plaintiff jury verdict for client Regeneron Pharmaceuticals, Inc. in Delaware federal court.
Won a major victory for CareDx by successfully persuading the Delaware District Court to grant CareDx’s post-trial motion for judgment as a matter of law.
Secured a complete appellate victory for Edwards Lifesciences in a patent infringement suit targeting the company’s transcatheter aortic valve replacement devices.
Practice head
Doug Lumish; Jeff Homrig
Other key lawyers
Gabe Gross; Gaby LaHatte